Optimal Dose of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Meta-Analysis

BACKGROUND: Erenumab is a novel monoclonal calcitonin gene-related peptide receptor antibody that is used for the preventive treatment of migraine. OBJECTIVES: This study aimed to evaluate the overall safety, efficacy, and dose-response relationship of erenumab in patients with episodic migraine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanbo, Chen, Mingjia, Wu, Da, Sun, Yue, Jiang, Fan, Chen, Zhouqing, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413785/
https://www.ncbi.nlm.nih.gov/pubmed/34429056
http://dx.doi.org/10.2174/1570159X19666210823104916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413785/
https://www.ncbi.nlm.nih.gov/pubmed/34429056
http://dx.doi.org/10.2174/1570159X19666210823104916

Ejemplares similares